Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 8 results found. Search for [ National Biopharma Mission ]

Results 1 to 8 of 8
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar
November 20, 2020
Since the pandemic, India has created a robust regulatory and collaborative ecosystem and partnerships between various stakeholders under the National Biopharma Mission (NBM) to speed up vaccine development


PTI
October 29, 2020
On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia


BusinessToday.In
September 16, 2020
Stocks to watch today on September 16: Aurobindo Pharma, SpiceJet, Future Enterprises, Infosys, IRB Infrastructure among others are the top stocks to watch out for in Wednesday's trading session.


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


PTI
July 16, 2020
ZyCoV-D and COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research, are the only two vaccine candidates to have got a nod from the drug regulatory body to conduct human trials


BusinessToday.In
July 15, 2020
Coronavirus vaccine update: In the human trials, Zydus will enroll over 1,000 subjects across multiple clinical study sites in the country


PTI
New Delhi, April 21, 2020
Development of a novel vaccine evaluation platform at National Institute of Immunology, an institute under the Department of Biotechnology, to support SARS-CoV-2 vaccine development has also been approved for financial support


PAGES 1 OF 1